Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ / shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Research and development expenses		$ (31)		$ (56)
Marketing, general and administrative expenses		(355)	(204)	(669)	(2,179)
Operating loss		(386)	(204)	(725)	(2,179)
Financing expenses, net:
Income (expenses) related to convertible loan terms		386	(702)	7	(797)
Other financing income (expenses), net		(6)	47	(17)	17
Financing income (expenses), net		380	(655)	(10)	(780)
Net loss attributable to common stockholders		$ (6)	$ (859)	$ (735)	$ (2,959)
Loss per common stock (basic and diluted)	[1]	$ (0)	$ (0)	$ (0)	$ (0)
Basic weighted average number of shares of common stock outstanding		942,568,006	942,568,006	942,568,006	942,568,006
Comprehensive loss:
Net loss		$ (6)	$ (859)	$ (735)	$ (2,959)
Other comprehensive income (loss) attributable to foreign currency translation		(5)		1
Comprehensive loss		$ (11)	$ (859)	$ (734)	$ (2,959)

[1] Represents an amount less than $0.01 per common stock.